IMAC (BACK) Revenue & Revenue Breakdown
IMAC Revenue Highlights
Latest Revenue (Y)
$5.20M
Latest Revenue (Q)
$56.30K
IMAC Revenue by Period
IMAC Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2023-12-31 | $5.20M | -67.89% |
| 2022-12-31 | $16.19M | 12.51% |
| 2021-12-31 | $14.39M | 12.08% |
| 2020-12-31 | $12.84M | -15.14% |
| 2019-12-31 | $15.13M | 125.73% |
| 2018-12-31 | $6.70M | 752.53% |
| 2017-12-31 | $786.02K | 5140.17% |
| 2016-12-31 | $15.00K | - |
IMAC generated $5.20M in revenue during NA 2023, up -67.89% compared to the previous quarter, and up 77.55% compared to the same period a year ago.
IMAC Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2024-09-30 | $56.30K | 257.46% |
| 2024-06-30 | $15.75K | 100.00% |
| 2024-03-31 | - | -100.00% |
| 2023-12-31 | $-5.00M | -419.52% |
| 2023-09-30 | $1.57M | 16.51% |
| 2023-06-30 | $1.34M | -35.80% |
| 2023-03-31 | $2.09M | -39.70% |
| 2022-12-31 | $3.47M | -8.32% |
| 2022-09-30 | $3.79M | -24.77% |
| 2022-06-30 | $5.03M | 29.22% |
| 2022-03-31 | $3.89M | -10.84% |
| 2021-12-31 | $4.37M | 25.26% |
| 2021-09-30 | $3.49M | 0.63% |
| 2021-06-30 | $3.47M | 13.09% |
| 2021-03-31 | $3.06M | -11.52% |
| 2020-12-31 | $3.46M | -0.42% |
| 2020-09-30 | $3.48M | 35.19% |
| 2020-06-30 | $2.57M | -22.55% |
| 2020-03-31 | $3.32M | -21.73% |
| 2019-12-31 | $4.24M | -2.58% |
| 2019-09-30 | $4.36M | 15.95% |
| 2019-06-30 | $3.76M | 35.63% |
| 2019-03-31 | $2.77M | -15.37% |
| 2018-12-31 | $3.27M | 29.59% |
| 2018-09-30 | $2.53M | 297.92% |
| 2018-06-30 | $634.70K | 136.96% |
| 2018-03-31 | $267.85K | -25.17% |
| 2017-12-31 | $357.96K | 16.69% |
| 2017-09-30 | $306.77K | 238.28% |
| 2017-06-30 | $90.69K | - |
IMAC generated $56.30K in revenue during Q3 2024, up 257.46% compared to the previous quarter, and up 4.19% compared to the same period a year ago.
IMAC Revenue Breakdown
IMAC Revenue Breakdown by Product
Quarterly Revenue by Product
| Product/Service | Mar 21 |
|---|---|
| Patient Revenues | $3.02M |
Latest
IMAC's latest quarterly revenue breakdown by segment (product or service), as of Mar 21: Patient Revenues (100.00%).
IMAC Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| HCA | HCA Healthcare | $70.60B | $17.49B |
| AGL | agilon health | $6.06B | $1.45B |
| ACHC | Acadia Healthcare | $3.15B | $815.63M |
| AMED | Amedisys | $2.35B | $587.67M |
| AVAH | Aveanna Healthcare | $2.02B | $509.02M |
| PIII | P3 Health Partners | $1.50B | $362.12M |
| LFST | LifeStance Health Group | $1.25B | $312.72M |
| PNTG | Pennant Group | $695.24M | $168.75M |
| TOI | Oncology Institute | $393.41M | $99.90M |
| AIRS | AirSculpt | $180.35M | $42.55M |
| BACK | IMAC | $5.20M | $56.30K |